Extension to CQTI571A2102 to Evaluate Long-term Safety, Tolerability and Efficacy of Imatinib in Severe Pulmonary Arterial Hypertension (PAH)

Mise à jour : Il y a 4 ans
Référence : NCT01392495

Femme et Homme

Extrait

This study was an extension to study CQTI571A2102 and was to evaluate the long-term safety, tolerability and efficacy of QTI571 (imatinib) in severe pulmonary arterial hypertension patients.


Critère d'inclusion

  • pulmonary arterial hypertension


Liens